QYX

Outpatient Cardiac Telemetry

Product code
QYX
Device name
Outpatient Cardiac Telemetry
Device class
Class 2
21 CFR
21 CFR 870.1025
Medical specialty
Cardiovascular
Marketing pathway
510(K)
510(k) clearances (last 3 years)
5
Summaries archived here
3 (direct download)
510(k) clearances (all years, FDA)
21 (all years; only the last 3 years are listed here)

FDA classification definition

Devices are intended to continuously record and analyze electrocardiograms for automatic detection and recording of cardiac electrical activity in an outpatient setting. Detected, notifiable events are transmitted to the prescribing clinician during the monitoring period by a 24/7 attended analysis center after review by a qualified individual. Devices may allow remote access and display of electrocardiograms acquired. Not for use for detection or notification of hemodynamically unstable or life-threatening arrhythmias or cardiac events requiring urgent medical response. Not intended for patients at elevated risk of serious cardiovascular events that would require prompt intervention. It is not intended for monitoring patients during cardiac rehabilitation outside of healthcare facilities. Devices are intended for prescription use only.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (5)

Last three years. Most recent: 2026-04-21.

NumberDecision dateApplicantDevice nameSummary
K2507932026-04-21RhythMedix, LLCRhythmStar System (SL)FDA
K2411792025-07-11VivaQuant, Inc.Rhythm Express Remote Cardiac Monitoring System (RX-…PDF
K2406532024-10-31Smartcardia SASmartCardia 7L Platform (MCT)FDA
K2400292024-10-21iRhythm Technologies, Inc.Zio AT® device (A100A1001)PDF
K2335842024-07-08RhythMedix, LLCRhythmStar SystemPDF

3 summaries are archived here for direct download.

Official FDA classification page: QYX
Classification and pathway per current FDA publications. Data from openFDA (CC0).